NCT01934582View on ClinicalTrials.gov

A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

UT-15C SR

DRUG

treprostinil diethanolamine

Open label study drug.

Trial Locations (1)

14623

University of Rochester Medical Center, Rochester

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY